Senores Pharmaceuticals Forms Joint Venture Amerisyn, LLC
Senores Pharmaceuticals Limited announced the formation of a joint venture company, Amerisyn, LLC, in North Carolina, USA, on April 4, 2026. The joint venture was established through an Operating Agreement dated April 2, 2026, involving the company’s wholly owned subsidiary, Senores Pharmaceuticals, Inc., USA ("SPI").SPI has subscribed to 70% of the membership interest in Amerisyn, LLC, which has become a step-down subsidiary of Senores Pharmaceuticals Limited. Amerisyn, LLC was formed on March 5, 2026, and is based in the United States of America.
Table: Details of Amerisyn, LLC
| Particulars | Description |
|---|---|
| Name of the Target Company | Amerisyn, LLC |
| Turnover | Not applicable as it is a newly formed entity. |
| Industry | Pharmaceuticals |
| Date of formation | March 05, 2026 |
| Date of subscription to membership interest | April 02, 2026 |
| Country of presence | United States of America |
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.